Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 21 Oct 2016
At a glance
- Drugs Dapagliflozin (Primary) ; Simvastatin; Valsartan
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 08 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 Mar 2009 Planned end date changed from 1 May 2009 to 1 Mar 2009 as reported by ClinicalTrials.gov.